View in EDS HTML Full Text PDF Full Text

Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma.

Saved in:
Bibliographic Details
Title: Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma.
Authors: Sidana S; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA. Surbhi.sidana@stanford.edu., Bankova AK; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.; National Specialized Hospital for Hematological Diseases, Sofia, Bulgaria., Hosoya H; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA., Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Holmes TH; Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, USA., Tamaresis J; Department of Biostatistics, Stanford University School of Medicine, Stanford, USA., Le A; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.; Jasper Therapeutics, Stanford, USA., Muffly LS; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA., Maysel-Auslender S; Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, USA., Johnston L; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA., Arai S; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA., Lowsky R; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA., Meyer E; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA., Rezvani A; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA., Weng WK; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA., Frank MJ; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA., Shiraz P; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA., Maecker HT; Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, USA., Lu Y; Department of Biostatistics, Stanford University School of Medicine, Stanford, USA., Miklos DB; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA., Shizuru JA; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.
Source: Blood cancer journal [Blood Cancer J] 2024 Oct 09; Vol. 14 (1), pp. 173. Date of Electronic Publication: 2024 Oct 09.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39384609
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sidana+S%22">Sidana S</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA. Surbhi.sidana@stanford.edu.<br /><searchLink fieldCode="AU" term="%22Bankova+AK%22">Bankova AK</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.; National Specialized Hospital for Hematological Diseases, Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Hosoya+H%22">Hosoya H</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Kumar+SK%22">Kumar SK</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Holmes+TH%22">Holmes TH</searchLink>; Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Tamaresis+J%22">Tamaresis J</searchLink>; Department of Biostatistics, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Le+A%22">Le A</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.; Jasper Therapeutics, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Muffly+LS%22">Muffly LS</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Maysel-Auslender+S%22">Maysel-Auslender S</searchLink>; Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Johnston+L%22">Johnston L</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Arai+S%22">Arai S</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Lowsky+R%22">Lowsky R</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Meyer+E%22">Meyer E</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Rezvani+A%22">Rezvani A</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Weng+WK%22">Weng WK</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Frank+MJ%22">Frank MJ</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Shiraz+P%22">Shiraz P</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Maecker+HT%22">Maecker HT</searchLink>; Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Lu+Y%22">Lu Y</searchLink>; Department of Biostatistics, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Miklos+DB%22">Miklos DB</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Shizuru+JA%22">Shizuru JA</searchLink>; Division of BMT and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2024 Oct 09; Vol. 14 (1), pp. 173. <i>Date of Electronic Publication: </i>2024 Oct 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39384609
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-024-01152-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 173
    Titles:
      – TitleFull: Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sidana S
      – PersonEntity:
          Name:
            NameFull: Bankova AK
      – PersonEntity:
          Name:
            NameFull: Hosoya H
      – PersonEntity:
          Name:
            NameFull: Kumar SK
      – PersonEntity:
          Name:
            NameFull: Holmes TH
      – PersonEntity:
          Name:
            NameFull: Tamaresis J
      – PersonEntity:
          Name:
            NameFull: Le A
      – PersonEntity:
          Name:
            NameFull: Muffly LS
      – PersonEntity:
          Name:
            NameFull: Maysel-Auslender S
      – PersonEntity:
          Name:
            NameFull: Johnston L
      – PersonEntity:
          Name:
            NameFull: Arai S
      – PersonEntity:
          Name:
            NameFull: Lowsky R
      – PersonEntity:
          Name:
            NameFull: Meyer E
      – PersonEntity:
          Name:
            NameFull: Rezvani A
      – PersonEntity:
          Name:
            NameFull: Weng WK
      – PersonEntity:
          Name:
            NameFull: Frank MJ
      – PersonEntity:
          Name:
            NameFull: Shiraz P
      – PersonEntity:
          Name:
            NameFull: Maecker HT
      – PersonEntity:
          Name:
            NameFull: Lu Y
      – PersonEntity:
          Name:
            NameFull: Miklos DB
      – PersonEntity:
          Name:
            NameFull: Shizuru JA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 10
              Text: 2024 Oct 09
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1